STE · 10-Q · 2026Q3 · Full report

Segment Revenue Performance

STERIS plc · 2026-11-05 · Importance 54 · Surprise 40

For the six months ended September 30, 2026, Healthcare revenue rose 8.1% to $2,170.8 million, AST revenue rose 5.4% to $593.2 million, and Life Sciences revenue rose 13.3% to $317.4 million. Healthcare growth reflected mid-single-digit volume gains and low-single-digit pricing gains; AST growth was primarily pricing-led, while Life Sciences growth reflected higher volume and low-single-digit pricing. Healthcare backlog increased to $455.5 million from $427.5 million year over year, attributed primarily to order and shipment timing and an acquisition; Life Sciences backlog declined to $93.4 million from $113.7 million, primarily due to strong capital-order shipments. Life Sciences capital-equipment revenue increased 36.9% in the six-month period, while Healthcare capital-equipment revenue increased 2.8%.